首页 | 本学科首页   官方微博 | 高级检索  
     

枫蓼肠胃康的研究进展
引用本文:赵丹,安妮,陈常玉,张彩云,桂梅,张小坡. 枫蓼肠胃康的研究进展[J]. 现代药物与临床, 2014, 29(12): 1446-1450
作者姓名:赵丹  安妮  陈常玉  张彩云  桂梅  张小坡
作者单位:1. 哈尔滨商业大学 生命科学与环境科学研究中心,黑龙江 哈尔滨 150076; 海南医学院 药学院,海南 海口 571101
2. 海南医学院 药学院,海南 海口,571101
基金项目:国家自然科学基金资助项目
摘    要:枫蓼肠胃康由牛耳枫、辣蓼组成。研究表明,该复方中含有补身烷倍半萜类、黄酮类、生物碱类、有机酸类等化学成分,具有保护胃黏膜、抗溃疡性结肠炎、抗炎镇痛、抗菌等多方面的药理作用。在临床上常用的有枫蓼肠胃康颗粒剂、片剂、冲剂等,多用于急性肠胃炎、肠易激综合征、溃疡性结肠炎等。综述枫蓼肠胃康化学成分、药理作用、临床应用的研究进展,为其进一步研究和开发提供科学依据。

关 键 词:枫蓼肠胃康  化学成分  药理作用  临床应用
收稿时间:2014-10-24

Research progress on Fengliao Changweikang
ZHAO Dan,AN Ni,CHEN Chang-yu,ZHANG Cai-Yun,GUI Mei and ZHANG Xiao-Po. Research progress on Fengliao Changweikang[J]. Drugs & Clinic, 2014, 29(12): 1446-1450
Authors:ZHAO Dan  AN Ni  CHEN Chang-yu  ZHANG Cai-Yun  GUI Mei  ZHANG Xiao-Po
Affiliation:Center of Research and Development on Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin 150076, China;School of Pharmacy, Hainan Medical University, Haikou 571101, China;Center of Research and Development on Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin 150076, China;School of Pharmacy, Hainan Medical University, Haikou 571101, China;Center of Research and Development on Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin 150076, China;School of Pharmacy, Hainan Medical University, Haikou 571101, China;School of Pharmacy, Hainan Medical University, Haikou 571101, China;School of Pharmacy, Hainan Medical University, Haikou 571101, China;School of Pharmacy, Hainan Medical University, Haikou 571101, China
Abstract:Fengliao Changweikang is composed of Daphniphyllum calycinum and Polygonum hydropiper. The study shows that Fengliao Changweikang contains sesquiterpenoids, flavonoids, alkaloids, and organic acids. These chemical constituents play important roles in protecting the stomach lining, anti-ulcerous colitis, anti-inflammation, and anti-microbial. Clinically, granules, tablets, and electuary are commonly prescribed by doctors to cure acute gastroenteritis, irritable bowel syndrome, and ulcerative colitis. This paper summarizes the research progress on chemical constituents, pharmacology, and clinic usage of Fengliao Changweikang to provide scientific evidence for further researches and development concerning this patent Chinese medicine.
Keywords:Fengliao Changweikang  chemical constituents  pharmacology  clinic usage
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号